Dow completes separation from DowDuPont

20:00 EDT 17 Apr 2019 | Australian Life Scientist

Dow has successfully completed its separation from DowDuPont, becoming a more focused and streamlined materials science company in the process.

The new company will be referred to by the brand name ‘Dow’, acknowledging its legacy while also reflecting the company-wide evolution to a materials science solutions provider. Dow is adopting a new brandline — ‘Seek Together’ — which is a call to action that highlights the value of collaboration to deliver innovation and solutions to its customers and value chains.

Dow launched on 1 April with global scale and leading positions in three consumer-driven segments: packaging, infrastructure and consumer care. The company believes it is now even better positioned to drive revenue growth and innovate for its customers, leveraging three building blocks — ethylene, propylene and silicones — to power one of the deepest chemistry sets in the industry.

“Today marks the beginning of a new and exciting chapter for Dow,” said Dow CEO Jim Fitterling on the day of the separation. “The changes we have made to Dow’s portfolio, cost structure and mindset are significant. The new Dow is a more focused and streamlined company with a clear playbook to deliver long-term earnings growth and value creation for all stakeholders.

“Team Dow is well positioned to achieve our ambition of becoming the most innovative, customer-centric, inclusive and sustainable materials science company. We have all the tools in place to innovate more quickly, to operate more productively and to invest more prudently to deliver value creating growth, higher returns and enhanced shareholder value.”

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Original Article: Dow completes separation from DowDuPont


More From BioPortfolio on "Dow completes separation from DowDuPont"

Quick Search


Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...